Opendata, web and dolomites

InterTAU SIGNED

Integrative structural biology of pathological tau protein, an appealing therapeutic target for Alzheimer´s disease modifying drugs

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 InterTAU project word cloud

Explore the words cloud of the InterTAU project. It provides you a very rough idea of what is the project "InterTAU" about.

bioinformatics    nuclear    molecular    transfer    conformationally    prevention    outcome    disease    characterization    diagnosis    platform    denominator    modifying    innovation    solution    mutual    pathogenesis    anti    america    envisaged    translated    sharing    microscopy    complementary    enormous    deeper    conformational    immunotherapy    ing    inducers    cooperation    functional    biophysical    cryo    tauopathies    pharmacological    nmr    solid    foundation    expertise    oligomeric    assembly    structural    pathology    toxicity    cellular    biotechnological    monomeric    argentina    electron    lacking    therapy    suitable    medical    resonance    clinical    efficient    therapies    company    assays    stage    academic    pathological    transferred    ad    oligomerization    variants    hampered    altered    intertau    tau    fibrillar    corroborated    sustainable    biotech    pharma    assembled    relates    there    course    unmet    edge    cutting    north    protein    alzheimer    pursuing    forms    magnetic   

Project "InterTAU" data sheet

The following table provides information about the project.

Coordinator
Masarykova univerzita 

Organization address
address: Zerotinovo namesti 9
city: BRNO STRED
postcode: 60177
website: http://www.muni.cz

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Czech Republic [CZ]
 Total cost 1˙062˙600 €
 EC max contribution 1˙058˙000 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2019
 Funding Scheme MSCA-RISE
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    Masarykova univerzita CZ (BRNO STRED) coordinator 441˙600.00
2    AXON NEUROSCIENCE R&D SERVICES SE SK (BRATISLAVA) participant 464˙600.00
3    LATVIJAS ORGANISKAS SINTEZES INSTITUTS LV (RIGA) participant 128˙800.00
4    ROYAL COLLEGE OF SURGEONS IN IRELAND IE (DUBLIN) participant 23˙000.00
5    OREGON STATE UNIVERSITY US (CORVALLIS) partner 0.00
6    UNIVERSIDAD NACIONAL DE CUYO AR (MENDOZA) partner 0.00
7    UNIVERSITY HEALTH NETWORK CA (TORONTO) partner 0.00
8    UNIVERSITY OF PITTSBURGH US (PITTSBURGH) partner 0.00

Map

 Project objective

There is an enormous and unmet medical need to find efficient methods of prevention, diagnosis and disease-modifying therapies for tauopathies, including Alzheimer’s disease. The common molecular denominator of tauopathies are pathological forms of tau protein. Tau pathology relates to conformational changes during oligomerization and assembly resulting in toxicity. Given its role in the pathogenesis, conformationally altered and assembled tau would be a promising molecular target for disease-modifying therapy. However, the field is still lacking a deeper understanding of tau structural changes in the course of assembly and their inducers on the pathway towards the pathological forms of Tau; therefore, the pharma development is hampered. The main aim of the InterTau project is the detailed structural and biophysical characterization of tau protein and its variants in monomeric, oligomeric and fibrillar states relevant for AD and other tauopathies. The InterTAU consortium is composed of a clinical-stage biotech company pursuing development of anti-tau immunotherapy and academic partners with cutting-edge methodologies suitable for functional and structural characterization of the tau assembly pathway by solution and solid-state nuclear magnetic resonance (NMR), cryo-electron microscopy and cellular assays corroborated by bioinformatics. The mutual transfer of complementary expertise envisaged in the project will facilitate academic outcome and biotechnological development. Specific expertise will be transferred from three institutions in North America and one institution from Argentina. The results of InterTAU will be directly translated into innovation in pharmacological development through the non-academic partner. The platform for sharing knowledge will be a foundation of sustainable cooperation beyond the InterTau project.

 Deliverables

List of deliverables.
Project website Websites, patent fillings, videos etc. 2020-04-03 12:46:44

Take a look to the deliverables list in detail:  detailed list of InterTAU deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INTERTAU" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INTERTAU" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

MAIL (2019)

Identifying Marginal Lands in Europe and strengthening their contribution potentialities in a CO2sequestration strategy

Read More  

DisTerrMem (2019)

Memory Across Borders: Dealing with the Legacy of Disputed Territories

Read More  

EventRights (2018)

Addressing inequality, enhancing diversity and facilitating greater dialogue in the hosting of sporting mega events.

Read More